المؤلفون: van Vlijmen EF; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. e.f.w.van.vlijmen@umcg.nl., Mäkelburg AB; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Knol HM; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Obstetrics and Gynaecology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Tichelaar VI; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Kluin-Nelemans HC; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Veeger NJ; Department of Clinical Epidemiology, University of Groningen, University Medical Centre, Groningen, The Netherlands., Meijer K; Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

المصدر: British journal of haematology [Br J Haematol] 2016 Feb; Vol. 172 (4), pp. 636-8. Date of Electronic Publication: 2015 Jun 24.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Contraceptives, Oral, Combined/*adverse effects , Contraceptives, Oral, Hormonal/*adverse effects , Venous Thromboembolism/*chemically induced, Adolescent ; Adult ; Female ; Humans ; Levonorgestrel/adverse effects ; Middle Aged ; Prospective Studies ; Recurrence ; Risk Factors ; Young Adult